I[ntroduction]{.smallcaps} {#sec1-1}
==========================

Pneumoconiosis is an occupational disease mainly caused by inhalation of microscopically respirable coal dust, crystalline silica particles, and other various dust particles. Clinically, pneumoconiosis is characterized by shortness of breath and chest X-ray patchy, subpleural or bibasilar interstitial infiltrates, or small cystic radiolucencies (honeycombing).\[[@ref1][@ref2][@ref3]\] Pathologically, the inhaled dust induces chronic lung inflammation and pulmonary fibrosis.\[[@ref1][@ref2][@ref3]\] Early pneumoconiosis may be asymptomatic, but advanced stages of pneumoconiosis result in airflow limitation, hypoxia, pulmonary hypertension, respiratory or heart failure, and premature death, even without further exposure to the dust.\[[@ref1][@ref2][@ref3]\]

Pathogenesis of pneumoconiosis is multifactorial, and different dust particles can induce relatively different host immune responses, which are controlled by expression of various genes and gene pathways.\[[@ref4][@ref5][@ref6]\] For example, it was reported that not all individuals exposed to similar levels of dust developed pulmonary fibrosis, which suggests that genetic predisposition plays a crucial role in individual pneumoconiosis susceptibility.\[[@ref7][@ref8]\] Therefore, a better understanding of the interaction between genetic mutations and dust exposure can help identify high-risk individuals and prevent pneumoconiosis development.

Transforming growth factor-β (TGF-β) is a multifunctional cytokine with various effects on cell proliferation, differentiation, apoptosis, migration, inflammation, tissue repair, and immune responses.\[[@ref9]\] The subtype *TGF-β1*, cloned from human placenta, is the most abundant isoform in the human body. As a growth factor with important immunomodulatory and fibrogenic properties, *TGF-β1* facilitates chemotaxis through stimulation of monocyte, lymphocyte, neutrophil, and myofibroblast migration. Thus, it may function as a candidate for pneumoconiosis.\[[@ref10][@ref11][@ref12][@ref13]\]

*TGF-β1* gene includes seven exons and six introns and is located at chromosome 19q13.\[[@ref14]\] Several polymorphic variants in *TGF-β1*, such as −509 C\>T (rs1800469), +869 T\>C (rs1800470), and +915 G\>C (rs1800471), were assessed for association with pneumoconiosis risk, the data remain controversial currently.\[[@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25]\] In 2012, a meta-analysis published in Chinese reported that *TGF-β1* gene −509 C\>T, +869 T\>C polymorphisms were not associated with risk of developing pneumoconiosis.\[[@ref26]\] However, only small sample size related to *TGF-β1* gene −509 C\>T, +869 T\>C was involved in this meta-analysis, and thus, it was unable to provide enough persuasiveness. It is unclear yet whether there are significant associations between −509 C\>T (rs1800469), +869 T\>C (rs1800470), and +915 G\>C (rs1800471) polymorphisms and the risk of pneumoconiosis. To summarize and clarify the published data, we performed this meta-analysis.

M[ethods]{.smallcaps} {#sec1-2}
=====================

Literature search strategy {#sec2-1}
--------------------------

We searched the electronic databases of PubMed, Embase, the Chinese Biomedical Database, and the Wei Pu (Chinese) Database to retrieve eligible studies for inclusion in this meta-analysis. The following terms were used in the search: "Pneumoconiosis" OR "silicosis" OR "asbestosis" AND "transforming growth factor β" OR "TGF-β" OR "TGF beta" AND "single nucleotide polymorphism" OR "polymorphisms," etc. These keywords were combined with Boolean logic words "OR/AND". Additional studies were identified by a manual search of the references of related articles, reviews, even citation tracking and so on, and the search included all published literature through April 30, 2016. In cases where publications used the same patient population, we only included the most recent or complete study in the meta-analysis.

Selection criteria {#sec2-2}
------------------

The inclusion criteria were as follows: (1) studies investigating the association between pneumoconiosis risk and *TGF-β1* polymorphisms −509 C\>T (rs1800469), +869 T\>C (rs1800470), and +915 G\>C (rs1800471); Any study about *TGF-β1* −509 C\>T (rs1800469) or +869 T\>C (rs1800470) or +915 G\>C (rs1800471) was considered as an independent study. (2) case--control studies; (3) studies providing sufficient information for genotype and allele frequencies to estimate the odds ratio (*OR*) with its corresponding 95% confidence interval (*CI*) and *P* values; (4) studies written in English or Chinese; (5) human studies; and (6) studies including only cases with definitive diagnosis of pneumoconiosis. The exclusion criteria were as follows: (1) case reports, abstracts, reviews, and repeat studies; (2) genotype distribution did not reach Hardy--Weinberg equilibrium (HWE).

Data extraction {#sec2-3}
---------------

The following data were independently extracted from all eligible publications by two investigators (Chang-Wen Deng and Xing-Xing Zhang) according to the inclusion criteria, and any disagreement was discussed with coauthors until a consensus was reached. A standardized data form was used that included first author\'s name, year of publication, country origin, study ethnicity, genotyping methods, total number of cases and controls, genotype distributions in cases and controls, source of controls, and information on HWE test. These data were also tracked manually if missing. Population categories were divided into Caucasian, Asian, and mixed.

Statistical analysis {#sec2-4}
--------------------

The pooled *OR*s with 95% *CI* were used to determine the association between risk of pneumoconiosis and *TGF-β1* polymorphisms −509 C\>T, +869 T\>C, and +915 G\>C according to allele contrast, homozygote, heterozygote, dominant, and recessive models. The pooled *OR*s were calculated for additive, codominant, dominant, and recessive models, respectively. The significance of pooled *OR*s was analyzed using the *Z*-test in recessive models. *P* \< 0.05 was considered statistically significant. The Chi-square-based Q statistic test, quantified by the *I*[@ref2] metric value, was used to analyze heterogeneity assumption among the studies (*I*[@ref2] \> 50% or *P* ≤ 0.1 was considered statistically significant. All *P* values were two-sided). When studies were homogenous, the fixed effects model (Mantel--Haenszel method) was performed. Otherwise, the random effects model was applied to estimate the *OR*s and 95% *CI* according to the previous studies.\[[@ref27][@ref28]\] The Chi-square test was used to test HWE. The statistical program STATA version 12.0 (StataCorp, College Station, TX, USA) was used to analyze all data in this study.

R[esults]{.smallcaps} {#sec1-3}
=====================

Characteristics of studied subjects {#sec2-5}
-----------------------------------

Based on our search strategy, 11 articles involving 21 studies were included in this meta-analysis, covering a total of 4333 cases with pneumoconiosis and 3478 controls. The controls were matched with those cases for age, dust exposure period and job type, etc. The study selection process is shown in [Figure 1](#F1){ref-type="fig"}. Seven of these studies investigated association between *TGF-β1* −509 C\>T polymorphism and pneumoconiosis,\[[@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21]\] nine involved +869 T\>C polymorphism,\[[@ref15][@ref17][@ref18][@ref19][@ref20][@ref22][@ref23][@ref24][@ref25]\] and five involved +915 G\>C polymorphism.\[[@ref15][@ref17][@ref19][@ref20][@ref24]\] The characteristics of each selected study are listed in Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}. Specifically, [Table 1](#T1){ref-type="table"} shows characteristics of case and control for association of −509 C\>T polymorphism with pneumoconiosis, six of which were performed in Asia.\[[@ref15][@ref17][@ref18][@ref19][@ref20][@ref21]\] One was performed in Caucasus,\[[@ref16]\] originating from China and USA, respectively. Pneumoconiosis was induced by coal in two studies, and others were induced by silicosis. However, there were only two studies that did not follow the HWE.\[[@ref18][@ref21]\] The characteristics of case and control for association of +869 T\>C polymorphism with pneumoconiosis are presented in [Table 2](#T2){ref-type="table"}. Seven studies were performed in Asia,\[[@ref15][@ref17][@ref18][@ref19][@ref20][@ref22][@ref25]\] one in Caucasus,\[[@ref24]\] and one in mixed\[[@ref23]\] and originated from China, German, Turkish, and the USA, respectively. Two studies did not follow the HWE, and one study had insufficient data for HWE calculation.\[[@ref18][@ref23]\] Pneumoconiosis was present in coal workers in four studies, and in five studies, silicosis was the irritant. [Table 3](#T3){ref-type="table"} illustrates the characteristics of case and control for association of +915 G\>C polymorphism with pneumoconiosis. Four studies were performed in China\[[@ref15][@ref17][@ref19][@ref20]\] and one in Caucasus in Germany.\[[@ref24]\] One study did not follow the HWE, and one study had insufficient data for HWE calculation.\[[@ref15][@ref17]\] Pneumoconiosis occurred in coal workers type reported in three studies and in silicosis in two studies.

![Illustration of study selection and inclusion process.](CMJ-130-357-g001){#F1}

###### 

Characteristics of enrolled case--control studies for association of −509 C\>T polymorphism with pneumoconiosis

  References                     Year   Ethnicity (country)   Subjects   Frequency of allele   Distribution of genotype   Pneumoconiosis type   Method of genotyping   HWE                                      
  ------------------------------ ------ --------------------- ---------- --------------------- -------------------------- --------------------- ---------------------- ----- ----- ----- ----------- ---------- --------
  Fan *et al*.\[[@ref15]\]       2007   Asian (China)         Case       131                   103                        234                   40                     51    26    117   Silicosis   PCR-RELP   0.08
  Control                        100    134                   234        26                    48                         43                    117                                                             
  Yucesoy *et al*.\[[@ref16]\]   2008   Caucasus (USA)        Case       171                   395                        566                   31                     109   143   283   CWP         PCR-SSP    0.08
  Control                        189    461                   650        34                    121                        170                   325                                                             
  Wu *et al*.\[[@ref17]\]        2008   Asian (China)         Case       175                   191                        366                   46                     83    54    183   Silicosis   PCR-RELP   0.42
  Control                        119    103                   222        34                    51                         26                    111                                                             
  Qian *et al*.\[[@ref18]\]      2010   Asian (China)         Case       515                   501                        1016                  121                    273   114   508   CWP         PCR-RELP   \<0.05
  Control                        546    506                   1052       122                   302                        102                   526                                                             
  Li *et al*.\[[@ref19]\]        2009   Asian (China)         Case       92                    62                         154                   28                     36    13    77    Silicosis   PCR-RELP   0.06
  Control                        70     84                    154        20                    30                         27                    77                                                              
  Li *et al*.\[[@ref20]\]        2010   Asian (China)         Case       41                    39                         80                    13                     15    12    40    CWP         PCR-RELP   0.80
  Control                        30     50                    80         6                     18                         16                    40                                                              
  Yao *et al*.\[[@ref21]\]       2006   Asian (China)         Case       124                   96                         220                   34                     56    20    110   CWP         PCR-RELP   \<0.05
  Control                        76     144                   220        18                    40                         52                    110                                                             

CWP: Coal workers' pneumoconiosis; HWE: Hardy--Weinberg equilibrium; PCR-SSP: Polymerase chain reaction-sequence-specific primer; PCR-RFLP: Polymerase chain reaction-restriction fragment length polymorphism.

###### 

Characteristics of enrolled case--control studies for association of +869 T\>C polymorphism with pneumoconiosis

  References                    Year   Ethnicity (country)   Subjects   Frequency of allele   Distribution of genotype   Pneumoconiosis type   Method of genotyping   HWE                                     
  ----------------------------- ------ --------------------- ---------- --------------------- -------------------------- --------------------- ---------------------- ----- ---- ----- ----------- ---------- --------
  Fan *et al*.\[[@ref15]\]      2007   Asian (China)         Case       106                   128                        234                   28                     50    39   117   Silicosis   PCR-RELP   0.17
  Control                       125    109                   234        37                    51                         29                    117                                                            
  Wu *et al*.\[[@ref17]\]       2008   Caucasus (USA)        Case       187                   179                        366                   52                     83    48   183   Silicosis   PCR-RELP   0.75
  Control                       104    118                   222        24                    56                         31                    111                                                            
  Qian *et al*.\[[@ref18]\]     2010   Asian (China)         Case       584                   432                        1016                  123                    338   47   508   CWP         PCR-RELP   \<0.05
  Control                       550    502                   1052       109                   332                        85                    526                                                            
  Li *et al*.\[[@ref19]\]       2009   Asian (China)         Case       70                    84                         154                   19                     32    26   77    Silicosis   PCR-RELP   0.31
  Control                       80     74                    154        23                    34                         20                    77                                                             
  Li *et al*.\[[@ref20]\]       2009   Asian (China)         Case       36                    44                         80                    9                      18    13   40    Silicosis   PCR-RELP   0.38
  Control                       45     35                    80         14                    17                         9                     40                                                             
  Yu *et al*.\[[@ref22]\]       2009   Asian (China)         Case       249                   219                        468                   74                     101   59   234   CWP         PCR-RELP   0.20
  Control                       464    416                   880        129                   206                        105                   440                                                            
  Ates *et al*.\[[@ref23]\]     2008   Mixed (Turky)         Case       60                    74                         134                   17                     26    24   67    CWP         PCR-RELP   \<0.05
  Control                       94     90                    184        22                    50                         20                    92                                                             
  Helmig *et al*.\[[@ref24]\]   2009   Caucasus (Germany)    Case       657                   457                        1114                  189                    279   89   557   CWP         PCR-SSP    0.38
  Control                       100    66                    166        32                    36                         15                    83                                                             
  Yu *et al*.\[[@ref25]\]       2009   Asian (China)         Case       264                   254                        518                   56                     --    --   56    Silicosis   PCR-RELP   
  Control                       341    341                   682        68                    --                         --                    68                                                             

CWP: Coal workers' pneumoconiosis; HWE: Hardy--Weinberg equilibrium; PCR-SSP: Polymerase chain reaction-sequence-specific primer; PCR-RFLP: Polymerase chain reaction-restriction fragment length polymorphism.

###### 

Characteristics of enrolled case--control studies for association of +915 G\>C polymorphism with pneumoconiosis

  References                    Year   Ethnicity (country)   Subjects   Frequency of allele   Distribution of genotype   Pneumoconiosis type   Method of genotyping   HWE                                    
  ----------------------------- ------ --------------------- ---------- --------------------- -------------------------- --------------------- ---------------------- ----- --- ----- ----------- ---------- --------
  Fan *et al*.\[[@ref15]\]      2007   Asian (China)         Case       200                   34                         234                   83                     34    0   117   Silicosis   PCR-RELP   \<0.05
  Control                       214    20                    234        97                    20                         40                    117                                                           
  Wu *et al*.\[[@ref17]\]       2008   Asian (China)         Case       364                   2                          294                   181                    2     0   183   Silicosis   PCR-RELP   \<0.05
  Control                       222    0                     222        111                   0                          0                     111                                                           
  Li *et al*.\[[@ref19]\]       2009   Asian (China)         Case       128                   26                         154                   51                     26    0   77    Silicosis   PCR-RELP   0.38
  Control                       140    14                    154        63                    14                         0                     77                                                            
  Li *et al*.\[[@ref20]\]       2009   Asian (China)         Case       72                    8                          80                    32                     8     0   40    CWP         PCR-RELP   0.60
  Control                       74     6                     80         34                    6                          0                     40                                                            
  Helmig *et al*.\[[@ref24]\]   2009   Caucasus (Germany)    Case       1025                  89                         640                   469                    87    1   557   CWP         PCR-SSP    0.55
  Control                       156    10                    166        73                    10                         0                     83                                                            

CWP: Coal workers' pneumoconiosis; HWE: Hardy--Weinberg equilibrium; PCR-SSP: Polymerase chain reaction-sequence-specific primer; PCR-RFLP: Polymerase chain reaction-restriction fragment length polymorphism.

Quantitative data synthesis {#sec2-6}
---------------------------

For *TGF-β1* −509 C\>T polymorphism, we conducted seven studies to evaluate the overall association between −509 C\>T polymorphism and risk of pneumoconiosis. We found an overall association between −509 C\>T polymorphism and the risk of pneumoconiosis in terms of allele frequency \[T vs. C, *OR* = 1.35, 95% *CI*: 1.00--1.81, *P* = 0.046; [Figure 2](#F2){ref-type="fig"}\]. However, there was no significant association detected under homozygous, heterozygous, recessive, and dominant models \[*P* \> 0.05; [Table 4](#T4){ref-type="table"}\]. The subgroup analysis showed that −509 C\>T polymorphism was not significantly associated with pneumoconiosis risk based on pneumoconiosis type and ethnicity.

![Forest plot that describes the meta-analysis under allele contrast model for association between transforming growth factor-β1 −509 C\>T polymorphism and pneumoconiosis risk (T vs. C), test for overall effect (z = 1.99, *P* = 0.046).](CMJ-130-357-g002){#F2}

###### 

Association of *TGF-β1*−509 C\>T, +869 T\>C, +915 G\>C polymorphisms with risk of pneumoconiosis

  *TGF-β1* polymorphisms   Allele contrast model   Homozygous model   Heterozygous model   Dominant model        Recessive model                                                                
  ------------------------ ----------------------- ------------------ -------------------- --------------------- --------------------- ------- ------------------- ------- -------------------- -------
  Overall                  1.35 (1.00, 1.81)       0.046              1.69 (0.98, 2.92)    0.059                 1.36 (0.90, 2.05)     0.14    1.48 (0.95, 2.31)   0.081   1.33 (0.98, 1.81)    0.071
  Type of diseases                                                                                                                                                                              
   Silicosis               1.32 (0.77, 2.28)       0.31               1.65 (0.62, 4.41)    0.32                  1.45 (0.73, 2.86)     0.28    1.54 (0.70, 3.41)   0.28    1.28 (0.72, 2.28)    0.39
   CWP                     1.38 (0.92, 2.07)       0.12               1.75 (0.81, 3.78)    0.15                  1.31 (0.74, 2.33)     0.34    1.46 (0.80, 2.68)   0.22    1.39 (0.90, 2.15)    0.13
  Ethnicity                                                                                                                                                                                     
   Caucasian               1.06 (0.83, 1.35)       0.66               1.08 (0.63, 1.85)    0.76                  1.07 (0.76, 1.51)     0.69    1.07 (0.78, 1.48)   0.66    1.05 (0.63, 1.76)    0.84
   Asian                   1.43 (0.99, 2.06)       0.060              1.87 (0.96, 3.66)    0.067                 1.46 (0.85, 2.50)     0.17    1.61 (0.90, 2.87)   0.19    1.41 (0.98, 2.04)    0.067
                                                                                                                                                                                                
  ***TGF-β1* +869 T\>C**   **C versus T**          **CC versus TT**   **CT versus TT**     **CT+CC versus TT**   **CC versus TT+TC**                                                            
                                                                                                                                                                                                
  Overall                  0.97 (0.89, 1.07)       0.58               1.05 (0.73, 1.52)    0.79                  0.95 (0.80, 1.13)     0.56    1.00 (0.86, 1.17)   0.96    1.09 (0.78, 1.51)    0.62
  Type of diseases                                                                                                                                                                              
   Silicosis               1.04 (0.89, 1.21)       0.64               1.23 (0.68, 2.23)    0.49                  0.97 (0.67, 1.40)     0.86    1.15 (0.88, 1.49)   0.29    1.22 (0.87, 1.72)    0.24
   CWP                     0.94 (0.83, 1.06)       0.29               0.97 (0.60, 1.55)    0.88                  0.94 (0.77, 1.15)     0.57    0.93 (0.77, 1.13)   0.47    1.02 (0.64, 1.64)    0.93
  Ethnicity                                                                                                                                                                                     
   Caucasian               1.05 (0.76, 1.47)       0.75               1.00 (0.52, 1.95)    0.98                  1.31 (0.79, 2.19)     0.29    1.22 (0.76, 1.97)   0.40    0.86 (0.47, 1.58)    0.63
   Mixed                   1.29 (0.82, 2.01)       0.26               1.55 (0.65, 3.70)    0.32                  0.67 (0.31, 1.48)     0.32    0.92 (0.45, 1.92)   0.83    2.01 (0.99, 4.06)    0.052
   Asian                   0.95 (0.86, 1.05)       0.34               1.02 (0.64, 1.62)    0.92                  0.92 (0.76, 1.12)     0.43    0.98 (0.83, 1.16)   0.84    1.04 (0.71, 1.51)    0.85
                                                                                                                                                                                                
  ***TGF-β1* +915 G\>C**   **C versus G**          **CC versus GG**   **CG versus GG**     **CC+CG versus GG**   **CC versus CG+GG**                                                            
                                                                                                                                                                                                
  Overall                  1.69 (1.19, 2.40)       0.004              0.47 (0.02, 11.64)   0.64                  1.79 (1.23, 2.60)     0.002   1.80 (1.24, 2.61)   0.002   0.45 (0.02, 11.14)   0.62
  Type of diseases                                                                                                                                                                              
   Silicosis               1.93 (1.24, 3.00)       0.004                                                         2.13 (1.33, 3.42)     0.002   2.13 (1.33, 3.42)   0.002                        
   CWP                     1.36 (0.76, 2.42)       0.29               0.47 (0.02, 11.64)   0.64                  1.37 (0.75, 2.50)     0.30    1.38 (0.76, 2.52)   0.29    0.45 (0.02, 11.14)   0.62
  Ethnicity                                                                                                                                                                                     
   Caucasian               1.35 (0.69, 2.66)       0.37               0.47 (0.02, 11.64)   0.64                  1.35 (0.67, 2.73)     0.39    1.37 (0.68, 2.76)   0.37    0.45 (0.02, 11.14)   0.62
   Asian                   1.84 (1.22, 2.77)       0.003                                                         2.01 (1.30, 3.12)     0.002   2.01 (1.30, 3.12)   0.002                        

CWP: Coal workers' pneumoconiosis; *OR*: Odds ratio; *CI*: Confidence interval; TGF-β1: Transforming growth factor-beta 1.

Moreover, *TGF-β1* +915 G\>C polymorphism was significantly associated with risk of pneumoconiosis under allele contrast, heterozygous, and dominant models \[C vs. G, *OR* = 1.69, 95% *CI*: 1.19--2.40, *P* = 0.004; CG vs. GG, *OR* = 1.79, 95% *CI*: 1.23--2.60, *P* = 0.002; CC+CG vs. GG, *OR* = 1.80, 95% *CI*: 1.24--2.61, *P* = 0.002; [Figure 3](#F3){ref-type="fig"}\]. Similarly, the subgroup study of ethnicity, allele contrast, heterozygous, and dominant models also indicated a significant association \[C vs. G, *OR* = 1.84, 95% *CI*: 1.22--2.77, *P* = 0.003; CG vs. GG, *OR* = 2.01, 95% *CI*: 1.30--3.12, *P* = 0.002; CC + CG vs. GG, *OR* = 2.01, 95% *CI*: 1.30--3.12, *P* = 0.002; [Table 4](#T4){ref-type="table"}\]. Furthermore, the subgroup analysis of pneumoconiosis types among silicosis, allele contrast, heterozygous, and dominant models also indicated a significant association \[C vs. G, *OR* = 1.93, 95% *CI*: 1.24--2.40, *P* = 0.004; CG vs. GG, *OR* = 2.13, 95% *CI*: 1.33--3.42, *P* = 0.002; CC + CG vs. GG, *OR* = 2.13, 95% *CI*: 1.33--3.42, *P* = 0.002; [Figure 4](#F4){ref-type="fig"}\]. However, there was no association observed between *TGF-β1* +915 G\>C polymorphism and risk of pneumoconiosis under other models between Caucasian and coal workers' pneumoconiosis (CWP) \[*P* \> 0.05; [Table 4](#T4){ref-type="table"}\].

![Forest plot that describes the meta-analysis under allele contrast model, homozygous model, and dominant model for the association between transforming growth factor-β1 +915 G\>C polymorphism and ethnicities of pneumoconiosis risk. Test for overall effect (\[a\] C vs. G: z = 2.91, *P* = 0.004; \[b\] CG vs. GG: z = 3.05, *P* = 0.002; \[c\] CC+CG vs. GG: z = 3.07, *P* = 0.002).](CMJ-130-357-g003){#F3}

![Forest plot that describes the meta-analysis under allele contrast model, homozygous model, and dominant model for association between transforming growth factor-β1 +915 G\>C polymorphism and diseases types of pneumoconiosis diseases risk. Test for overall effect (\[a\] C vs. G: *z* = 2.91, *P* = 0.004; \[b\] CG vs. GG: *z* = 3.05, *P* = 0.002; \[c\] CC+CG vs. GG: *z* = 3.07, *P* = 0.002).](CMJ-130-357-g004){#F4}

However, for *TGF-β1* +869 T\>C polymorphism, there were nine studies and our analyses showed no statistically significant association between *TGF-β1* +869 T\>C polymorphism and the risk of pneumoconiosis under heterozygous, homozygous, allele contrast, recessive, and dominant models \[*P* \> 0.05; [Table 4](#T4){ref-type="table"}\]. Similarly, the subgroup study of ethnicity and pneumoconiosis types also showed no significant association between *TGF-β1* +869 T\>C polymorphism and increased risk of pneumoconiosis under all models \[*P* \> 0.05; [Table 4](#T4){ref-type="table"}\].

Sensitivity analysis and publication bias {#sec2-7}
-----------------------------------------

Sensitivity analysis was performed to reflect the influence of the individual data set on the pooled *OR*s by sequentially excluding each case--control study. The data showed that the corresponding pooled *OR*s under all the genetic models were not materially altered.

Begg\'s funnel plot and Egger\'s regression test were used to check publication bias in our data. Begg\'s funnel plots did not reveal obvious asymmetry \[Figures [5](#F5){ref-type="fig"}--[7](#F7){ref-type="fig"}\]. There were no statistically significant difference in the Egger\'s test, indicating that there was no significant publication bias for all genetic models (*TGF-β1* −509 C\>T polymorphism, *P* = 0.230 for T vs. C, *P* = 0.13 for CT vs. CC; *TGF-β1* +869 T\>C polymorphism, *P* = 0.10 for CC vs. TT; *P* = 0.90 for CT vs. TT; *TGF-β1* +915 G\>C polymorphism, *P* = 0.80 for C vs. G; *P* = 1.00 for CG vs. GG).

![Publication bias analyzed by the funnel plot for association between transforming growth factor-β1 −509 C\>T polymorphisms and the risk of pneumoconiosis under the recessive model.](CMJ-130-357-g005){#F5}

![Publication bias analyzed by the funnel plot for association between transforming growth factor-β1 +869 T\>C polymorphisms and the risk of pneumoconiosis under the dominant model.](CMJ-130-357-g006){#F6}

![Publication bias analyzed by the funnel plot for association between transforming growth factor-β1 +915 G\>C polymorphisms and the risk of pneumoconiosis under the dominant model.](CMJ-130-357-g007){#F7}

D[iscussion]{.smallcaps} {#sec1-4}
========================

In this meta-analysis, we searched the literature and obtained 21 eligible case--control studies with a total of 4333 pneumoconiosis cases and 3478 controls. Our data provided evidence for statistically significant association between *TGF-β1* −509 C\>T and +915 G\>C polymorphisms with risk of pneumoconiosis development. However, we did not find an association between *TGF-β1* +869 T\>C polymorphism and risk of pneumoconiosis. Further study will investigate the role of *TGF-β1* on regulation of lung cell fibrosis and pneumoconiosis development.

Pneumoconiosis is a multifactorial disease, and the causes can be silicosis, coal, and other duct irritants. Pneumoconiosis workers develop progressive massive fibrosis in the lung after chronic dust inhalation, which involves complex gene--gene and gene--environment interactions. However, not all individuals who are exposed to the similar levels of dust develop pulmonary fibrosis. It is suggested that there is a genetic association for the development of pneumoconiotic diseases. Indeed, lung fibrosis generally results from dust-induced inflammation, wound healing, and scar formation that lead to serious breathing problems. *TGF-β1* plays an important role by affecting wound healing and immunoresponses.\[[@ref9][@ref29]\] Furthermore, many candidate genes have been evaluated for associations between genetic variability and pneumoconiosis susceptibility. To some extent, validation studies of most genetic polymorphisms and pneumoconiosis have been performed with diverse populations for identifying high-risk individuals for prevention and treatment, such as interleukin-1 and tumor necrosis factor gene families.\[[@ref7][@ref30][@ref31][@ref32]\]

*TGF-β1* variants are of great importance in genetic modification of lung disease.\[[@ref33][@ref34]\] For example, overexpression of *TGF-β1* occurs in lung tissue in animal models and patients with pulmonary fibrosis,\[[@ref35][@ref36][@ref37][@ref38]\] and the association between pulmonary fibrosis susceptibility and *TGF-β1* gene polymorphisms has been investigated.\[[@ref39][@ref40][@ref41]\] Yao *et al*.\[[@ref42]\] showed that *TGF-β1* −509 polymorphism influenced serum level of *TGF-β1* in CWP. A previous study reported by Yucesoy *et al*.\[[@ref16]\] indicated that *TGF-β1* +869 variants were associated with susceptibility to CWP development while Qian *et al*.\[[@ref18]\] demonstrated that some representative genetic variants in *TGF-β1* may exert a role in CWP risk. In contrast, Wu *et al*.\[[@ref17]\] found that there were no associations between *TGF-β1* polymorphisms at positions −509, +869, and +915 with silicosis risk in Chinese iron miners, even an analysis did by Liu *et al*.\[[@ref26]\] showed that there were no associations between *TGF-β1* polymorphisms at positions −509 and +869 with pneumoconiosis. These inconsistent results prompted us to perform this meta-analysis due to larger sample size.

Meta-analyses can utilize different studies to enlarge the sample size and subsequently enhance the statistical power.\[[@ref43]\] In the current meta-analysis, we obtained 21 case--control studies with a total of 4,333 pneumoconiosis and 3478 controls. Our data showed an association between *TGF-β1* −509 C\>T and +915 G\>C polymorphism and the risk of pneumoconiosis in terms of the frequency of allele comparison. Furthermore, the subgroup study of ethnicity Asian and pneumoconiosis types among silicosis indicated a significant association with *TGF* +915 G\>C polymorphism. However, there was no significant association detected under homozygous, heterozygous, recessive, and dominant models as well as the subgroup analysis of pneumoconiosis type and ethnicity with *TGF-β1* −509 C\>T polymorphism. There was also no significant association between *TGF-β1* +869 T\>C polymorphism and the risk of pneumoconiosis, consistent with the subgroup analysis by the type of pneumoconiosis.

However, there are several limitations and potential bias which need further considering about how to interpret our meta-analysis. First, although we employed a thorough literature search strategy to identify qualified studies, a few studies may not get involved in the meta-analysis. Second, individuals in most studies were Chinese patients and the sample size of each study was relatively small in the ethnic standardized analysis, especially among Caucasian and the mixed. Third, there were no enough data included in the meta-analysis, especially some environmental factors, such as asbestos, biomass fuels, and wood chips associated with pneumoconiosis. Finally, due to limited data extraction from original studies, our current meta-analysis was mainly based on an unadjusted assessment and all genetic meta-analyses.

In conclusion, this study demonstrated that *TGF-β1* +869 T\>C polymorphism was not associated with risk of pneumoconiosis, whereas *TGF-β1* −509 C\>T and +915 G\>C were associated with risk of pneumoconiosis. It will be necessary to perform a prospective study via using standardized and unbiased genotyping methods in further study. Such a study will eventually lead to a comprehensive understanding of association of *TGF-β1* gene polymorphisms with pneumoconiosis risk and therefore identifying high-risk individuals for prevention and treatment of this disease.
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